Have a feature idea you'd love to see implemented?
Let us know!
MNKD Mannkind Corp
Price (delayed)
$6.9
Market cap
$1.9B
P/E Ratio
86.25
Dividend/share
N/A
EPS
$0.08
Enterprise value
$2.32B
MannKind Corporation focuses on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. MannKind is currently commercializing Afrezza® (insulin human) Inhalation Powder, its
Highlights
Mannkind's net income has soared by 169% YoY and by 84% from the previous quarter
Mannkind's EPS has soared by 167% YoY and by 60% from the previous quarter
The company's debt rose by 26% YoY and by 2.3% QoQ
Key stats
What are the main financial stats of MNKD
Market
Valuations
Earnings
Shares outstanding
275.78M
Market cap
$1.9B
Enterprise value
$2.32B
Price to earnings (P/E)
86.25
Price to book (P/B)
N/A
Price to sales (P/S)
7.1
EV/EBIT
38.12
EV/EBITDA
33.74
EV/Sales
8.69
Revenue
$267.2M
EBIT
$60.89M
EBITDA
$68.79M
Free cash flow
$28.87M
Per share
Balance sheet
Liquidity
EPS
$0.08
Free cash flow per share
$0.1
Book value per share
-$0.76
Revenue per share
$0.97
TBVPS
$1.66
Total assets
$464.2M
Total liabilities
$674.13M
Debt
$481.42M
Equity
-$209.93M
Working capital
$255.56M
Debt to equity
-2.29
Current ratio
4.54
Quick ratio
3.75
Net debt/EBITDA
6.08
Margins
Efficiency
Dividend
EBITDA margin
25.7%
Gross margin
71.9%
Net margin
8.1%
Operating margin
21.4%
Return on assets
4.6%
Return on equity
N/A
Return on invested capital
8.5%
Return on capital employed
15.5%
Return on sales
22.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MNKD stock price
How has the Mannkind stock price performed over time
Intraday
0.29%
1 week
-1.71%
1 month
4.23%
1 year
85.98%
YTD
89.56%
QTD
9.7%
Financial performance
How have Mannkind's revenue and profit performed over time
Revenue
$267.2M
Gross profit
$192.14M
Operating income
$57.25M
Net income
$21.57M
Gross margin
71.9%
Net margin
8.1%
Mannkind's net income has soared by 169% YoY and by 84% from the previous quarter
The company's net margin has surged by 146% YoY and by 72% QoQ
Mannkind's gross profit has soared by 66% YoY and by 9% from the previous quarter
The revenue has soared by 51% YoY and by 8% from the previous quarter
Growth
What is Mannkind's growth rate over time
Valuation
What is Mannkind stock price valuation
P/E
86.25
P/B
N/A
P/S
7.1
EV/EBIT
38.12
EV/EBITDA
33.74
EV/Sales
8.69
Mannkind's EPS has soared by 167% YoY and by 60% from the previous quarter
The equity has increased by 17% year-on-year and by 7% since the previous quarter
The revenue has soared by 51% YoY and by 8% from the previous quarter
The P/S is 27% higher than the last 4 quarters average of 5.6 but 24% lower than the 5-year quarterly average of 9.4
Efficiency
How efficient is Mannkind business performance
The ROA has soared by 145% YoY and by 70% QoQ
Mannkind's ROS has increased by 21% from the previous quarter
The company's return on invested capital rose by 18% QoQ
Dividends
What is MNKD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MNKD.
Financial health
How did Mannkind financials performed over time
The company's total assets is 31% lower than its total liabilities
Mannkind's quick ratio has surged by 122% YoY and by 10% QoQ
The company's current ratio has surged by 94% YoY and by 12% QoQ
The debt to equity has dropped by 51% year-on-year and by 10% since the previous quarter
The company's debt rose by 26% YoY and by 2.3% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.